|
"We have currently have substantial number of licensed seats and are in negotiations with Kinematik to expand that number. eNovator is primarily deployed within our Genome Sequencing Platform - so the majority of our users are molecular biologists, engineers, chemical engineers, bioinformatics specialists or management personnel.
The general opinion of users is very positive as demonstrated by the growth in the user population. Due to the diversity of the user population it is somewhat difficult to identify universal primary benefits. As an organization, however, the primary benefit
is our greatly enhanced ability to collaborate. Since information is efficiently stored and organized, it can be readily shared with distributed project teams - which has proven extraordinarily beneficial. From a management perspective, the ability to track progress in real time for active projects is one of the primary advantages.
We are using more and more of
the eNovator functionality as time progresses. The
electronic lab notebook was the most useful
component initially but, as we populated the
system with increasing amounts of project
information, more of the project management tools
became useful. As people began to execute more and
more projects "in eNovator" the ability to
coordinate using task lists (for example) also
became useful."
------------------------
Keith O'Neil
Special Projects Manager & Genome Finishing Laboratory Manager
|
